Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Eggert, Angelika" or (type exact bookEditor and editor="Eggert, Angelika")

Add to list
- Journal Article
- A1
- open access
A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

Lucas Matthyssens (UGent) , Jed G. Nuchtern, Cees P. Van De Ven, Hany O. S. Gabra, Kristin Bjornland, Sabine Irtan, Jakob Stenman, Luca Pio, Kate M. Cross, Stefano Avanzini, et al.

(2022) ANNALS OF SURGERY. 275(3). p.E575-E585
Add to list
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Laura D. Gamble, Stefania Purgato, Michelle J. Henderson, Simone Di Giacomo, Amanda J. Russell, Paolo Pigini, Jayne Murray, Emanuele Valli, Giorgio Milazzo, Federico M. Giorgi, et al.

(2021) CANCERS. 13(8).
Add to list
- Journal Article
- A1
Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68
Add to list
- Conference Paper
- C3
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Laura Gamble, Stefania Purgato, Simone Di Giacomo, Amanda Russell, Paolo Pigini, Emanuele Valli, Lesley Ashton, Tom Van Maerken (UGent) , Jo Vandesompele (UGent) , Rogier Versteeg, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Journal Article
- A1
A mechanistic classification of clinical phenotypes in neuroblastoma.

Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke, et al.

(2018) SCIENCE. 362(6419). p.1165-1170
Add to list
- Journal Article
- A1
- open access
Targeting tachykinin receptors in neuroblastoma

Anton G Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Simon Schäfers, Katleen De Preter (UGent) , Kathy Astrahanseff, et al.

(2017) ONCOTARGET. 8(1). p.430-443
Add to list
- Journal Article
- A1
Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Lucas Moreno, Hubert Caron, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Penelope Brock, Dominique Valteau-Couanet, Louis Chesler, Johannes Schulte, Katleen De Preter (UGent) , et al.

(2017) EXPERT OPINION ON DRUG DISCOVERY. 12(8). p.801-811
Add to list
- Journal Article
- A1
Targeting MYCN-driven transcription by BET-bromodomain inhibition

Anton G Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers (UGent) , Richard Koche, Franki Speleman (UGent) , Simon Schaefer, Emma Bell, Maike Nortmeyer, Frank Westermann, et al.

(2016) CLINICAL CANCER RESEARCH. 22(10). p.2470-2481
Add to list
- Journal Article
- A1
- open access
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Johannes Fabian, Desirée Opitz, Kristina Althoff, Marco Lodrini, Barbara Hero, Ruth Volland, Anneleen Beckers (UGent) , Katleen De Preter (UGent) , Anneleen Decock (UGent) , Nitin Patil, et al.

(2016) ONCOTARGET. 7(41). p.66344-66359
Add to list
- Journal Article
- A1
- open access
Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Melanie Schwermer, Sangkyun Lee, Johannes Koester, Tom Van Maerken (UGent) , Harald Stephan, Angelika Eggert, Katharina Morik, Johannes H Schulte and Alexander Schramm

(2015) ONCOTARGET. 6(17). p.15425-15435
Add to list
- Journal Article
- A1
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin

Kristina Althoff, Sven Lindner, Andrea Odersky, Pieter Mestdagh (UGent) , Anneleen Beckers (UGent) , Sarah Karczewski, Jan J Molenaar, Anna Bohrer, Shirley Knauer, Franki Speleman (UGent) , et al.

(2015) INTERNATIONAL JOURNAL OF CANCER. 136(6). p.1308-1320
Add to list
- Journal Article
- A1
- open access
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

Kristina Althoff, Anneleen Beckers (UGent) , Emma Bell, Maike Nortmeyer, Theresa Thor, Annika Sprüssel, Sven Lindner, Katleen De Preter (UGent) , Alexandra Florin, Lukas C Heukamp, et al.

(2015) ONCOGENE. 34(26). p.3357-3368
Add to list
- Conference Paper
- C3
Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Anton Henssen, Kristina Althoff, Richard Koche, Andrea Odersky, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Simon Schaefers, Katleen De Preter (UGent) , Alexandra Florin, Lukas Heukamp, et al.

(2015) Cancer Res.. In CANCER RESEARCH 75(suppl. 15).
Add to list
- Journal Article
- A1
MiR-34a deficiency accelerates medulloblastoma formation in vivo

Theresa Thor, Annette Künkele, Kristian W Pajtler, Annika K Wefers, Harald Stephan, Pieter Mestdagh (UGent) , Lukas Heukamp, Wolfgang Hartmann, Jo Vandesompele (UGent) , Natalie Sadowski, et al.

(2015) INTERNATIONAL JOURNAL OF CANCER. 136(10). p.2293-2303
Add to list
- Journal Article
- A1
Mutational dynamics between primary and relapse neuroblastomas

Alexander Schramm, Johannes Köster, Yassen Assenov, Krstina Althoff, Martin Peifer, Ellen Mahlow, Andrea Odersky, Daniela Beisser, Corinna Ernst, Anton G Henssen, et al.

(2015) NATURE GENETICS. 47(8). p.872-877
Add to list
- Journal Article
- A1
Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann, et al.

(2015) NATURE. 526(7575). p.700-704
Add to list
- Conference Paper
- C3
Reduced DICER1 functionality in neuroblastoma through reduced expression levels or somatic mutations

Bram De Wilde (UGent) , Johannes H Schulte, Anneleen Beckers (UGent) , Alexander Schramm, Annelies Fieuw (UGent) , Daniel Carter, Belamy Cheung, Glenn Marshall, Angelika Eggert, Katleen De Preter (UGent) , et al.

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
Targeted analysis of TP53 pathway SNPs in neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) Translational genetics : from cage over bench to bed.
Add to list
- Conference Paper
- C3
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) OncoPoint, 2nd Meeting, Abstracts.

Academic Bibliography

A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

A mechanistic classification of clinical phenotypes in neuroblastoma.

Targeting tachykinin receptors in neuroblastoma

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Targeting MYCN-driven transcription by BET-bromodomain inhibition

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

MiR-34a deficiency accelerates medulloblastoma formation in vivo

Mutational dynamics between primary and relapse neuroblastomas

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Reduced DICER1 functionality in neuroblastoma through reduced expression levels or somatic mutations

Targeted analysis of TP53 pathway SNPs in neuroblastoma patients

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Contents

Support

Contact